Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 250-063-5 | CAS number: 30125-47-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
No studies on skin sensitization were available for the test substance. Therefore, read across on reliable data from two analogue substances was performed.
- LLNA: read across to CAS 386254-45-1, according to OECD 429, GLP, mouse, not sensitising
- LLNA: read across to CAS 106276-79-3, according to OECD 429, GLP, mouse, not sensitising
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Parameter:
- SI
- Test group / Remarks:
- 3, 10, 30% test item concentration
- Remarks on result:
- other: The lymph node cell counts were only statistically increased in mice treated with the 3% test substance concentration, which do not display a concentration related change.
- Parameter:
- SI
- Value:
- 0.83
- Test group / Remarks:
- 1% test item concentration
- Parameter:
- SI
- Value:
- 1.03
- Test group / Remarks:
- 2% test item concentration
- Parameter:
- SI
- Value:
- 0.96
- Test group / Remarks:
- 5% test item concentration
Reference
Result #1: CAS 386254-45-1
Result # 2, 3, 4: CAS 106276-79-3
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The skin sensitization potential of the test item was not evaluated. However, reliable, experimental data of two structural analogues are available.
The skin sensitising potential of the structurally analogue substance (CAS 386254-45-1) was assessed using the Murine Local Lymph Node Assay (LLNA) performed according to GLP and OECD Guideline 429. Groups of 6 female CBA/Ca mice each were treated with 25 μl per ear of 3 %, 10 % and 30 % w/w preparations of the test substance in DAE 4:3:3 or with the vehicle alone to the dorsum of both ears for three consecutive days. An additional control group remained untreated to serve as a control for the immunological status of the animals. No signs of systemic toxicity were noticed. The test substance did not induce a statistically significant and biologically relevant increase in lymph node weights at the concentrations tested. The lymph node cell counts were only statistically increased in mice treated with the 3 % test substance concentration. Both parameters do not display concentration related changes. Treatment of the mice with 30 % test substance preparations induced a statistically significant increase in ear weights as compared to the vehicle control group. Due to observed rests of test substance on the ears of the mice applied with the 30 % and 10 % test substance concentrations, it remains unclear, whether the increased ear weights of the 30 % test substance concentration were partly due to rests of test substance or fully attributable to irritating properties. A 30 % suspension was the highest concentration of the test substance preparation suitable for application. From the results of the study it is concluded, that the test item does not have a skin sensitizing effect in the Murine Local Lymph Node Assay under the test conditions chosen.
A LLNA was conducted with a structurally analogue substance (CAS 106276-79-3) according to the OECD Guideline 429 and GLP in mice (CBA/CaOlaHsd). Test item suspensions at different concentrations (1, 2 and 5 % w/w) were prepared using DMSO as a vehicle. The animals did not show any signs of systemic toxicity during the course of the study and no cases of mortality were observed. On day 6, all test item treated animals showed scabby ear skin. A possible erythema of the ear skin could not be evaluated due to the colour of the test item. A statistically significant increase in ear weights was observed in the high dose group in comparison to the vehicle control group (p < 0.05). However, this was considered as not biologically relevant, as the observed increase did not exceed the threshold value of 25 % for excessive local skin irritation mentioned in the OECD Guideline. Nevertheless, the increase in ear weights indicates a slight irritant property of the test item. In this study Stimulation Indices (S.I.) of 0.83, 1.03 and 0.96 were determined with the test item at concentrations of 1, 2 and 5 %, respectively. A statistically significant or biologically relevant increase in DPM values, lymph node weights and lymph node cell counts was not observed in any treated group in comparison to the vehicle control group. Furthermore, the cut-off value of 1.55 for a positive response regarding the lymph node cell count index reported for BALB/c mice was not exceeded in any dose group. Thus, the test item was not a skin sensitiser under the test conditions of this study.
Based on the physico-chemical, structural as well as toxicoligical similarities, the same outcome is assumed for the actual substance.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. The stimulation indices in the LLNA (OECD 429) did not show a dose dependent increase. No EC3 could be established. As a result, the substance is not considered to be classified for skin sensitization under Regulation (EC) No. 1272/2008, as amended for the fourteenth time in Regulation (EC) No. 2020/217.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)